John V Conaglen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John V Conaglen

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Human Pathology|January 3, 2015

Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomasMarianne S Elston, Goswin Y Meyer-Rochow, Helen M Conaglen, et al.

The Journal of Clinical Endocrinology and Metabolism|January 23, 2009

Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomasMarianne S Elston, Anthony J Gill, John V Conaglen, et al.

Clinical Endocrinology|May 26, 2011

Mortality and morbidity in Cushing's syndrome in New ZealandMark J Bolland, Ian M Holdaway, Juliet E Berkeley, et al.

The Journal of Physiology|December 3, 2008

The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormoneJenny M Oldham, Claire C Osepchook, Ferenc Jeanplong, et al.

Endocrinology|December 15, 2007

Wnt pathway inhibitors are strongly down-regulated in pituitary tumorsMarianne S Elston, Anthony J Gill, John V Conaglen, et al.

Endocrine-Related Cancer|July 13, 2010

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targetsGoswin Y Meyer-Rochow, Nicole E Jackson, John V Conaglen, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Human Pathology|January 3, 2015

Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomasMarianne S Elston, Goswin Y Meyer-Rochow, Helen M Conaglen, et al.

The Journal of Clinical Endocrinology and Metabolism|January 23, 2009

Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomasMarianne S Elston, Anthony J Gill, John V Conaglen, et al.

Clinical Endocrinology|May 26, 2011

Mortality and morbidity in Cushing's syndrome in New ZealandMark J Bolland, Ian M Holdaway, Juliet E Berkeley, et al.

The Journal of Physiology|December 3, 2008

The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormoneJenny M Oldham, Claire C Osepchook, Ferenc Jeanplong, et al.

Endocrinology|December 15, 2007

Wnt pathway inhibitors are strongly down-regulated in pituitary tumorsMarianne S Elston, Anthony J Gill, John V Conaglen, et al.

Endocrine-Related Cancer|July 13, 2010

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targetsGoswin Y Meyer-Rochow, Nicole E Jackson, John V Conaglen, et al.

Pageof 5